Lunai Bioworks Inc. (LNAI)
OTCMKTS · Delayed Price · Currency is USD
0.1648
-0.0713 (-30.20%)
At close: Oct 29, 2026
Lunai Bioworks Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue | 0.05 | - | - | - | - |
Revenue Growth | - | - | - | - | - |
Gross Profit | 0.05 | - | - | - | - |
Selling, General & Admin | 7.8 | 17.88 | 24.56 | 15.32 | 14.33 |
Research & Development | 0.02 | 0.54 | 2.71 | 4.17 | 8.37 |
Operating Expenses | 7.92 | 18.55 | 27.39 | 19.6 | 22.83 |
Operating Income | -7.87 | -18.55 | -27.39 | -19.6 | -22.83 |
Interest Expense | -0.24 | -0.73 | -1.01 | -0.58 | -0.37 |
Interest & Investment Income | 0.02 | 0.12 | - | - | - |
Currency Exchange Gain (Loss) | - | - | - | -0 | 0 |
Other Non Operating Income (Expenses) | - | - | -1.42 | -0.13 | 0.12 |
EBT Excluding Unusual Items | -8.08 | -19.16 | -29.82 | -20.3 | -23.08 |
Impairment of Goodwill | - | -170.42 | -11.64 | - | - |
Gain (Loss) on Sale of Investments | 0.16 | -0.11 | - | - | - |
Asset Writedown | -0.83 | - | -42.61 | -18.96 | -93.25 |
Other Unusual Items | 5.19 | 11.68 | -4.35 | -0.42 | 2.9 |
Pretax Income | -3.56 | -178.01 | -88.43 | -39.68 | -113.43 |
Income Tax Expense | - | - | - | - | 0 |
Net Income | -3.56 | -178.01 | -88.43 | -39.68 | -113.43 |
Net Income to Common | -3.56 | -178.01 | -88.43 | -39.68 | -113.43 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 |
Shares Change | 62.89% | 69.27% | 73.31% | 7.12% | 11.37% |
EPS (Basic) | -1.06 | -86.27 | -72.55 | -56.42 | -172.76 |
EPS (Diluted) | -1.06 | -86.27 | -72.55 | -56.42 | -172.76 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -5.29 | -7.87 | -11.04 | -11.8 | -15.74 |
Free Cash Flow Per Share | -1.57 | -3.82 | -9.06 | -16.78 | -23.97 |
Gross Margin | 100.00% | - | - | - | - |
Operating Margin | -15129.28% | - | - | - | - |
Profit Margin | -6851.98% | - | - | - | - |
Free Cash Flow Margin | -10173.56% | - | - | - | - |
EBITDA | -7.81 | -18.42 | -27.27 | -19.48 | -22.7 |
D&A For EBITDA | 0.06 | 0.13 | 0.12 | 0.11 | 0.12 |
EBIT | -7.87 | -18.55 | -27.39 | -19.6 | -22.83 |